Eli Lilly's Foundayo pill reduces severity of sleep apnea in obese adults

Eli Lilly is preparing to file for U.S. approval of Foundayo, a daily pill aimed at treating moderate-to-severe obstructive sleep apnea in adults with obesity. This development marks a potential new pharmaceutical option for managing sleep apnea severity in this patient group.

Originally published by gnews